Coverage and reimbursement of biomarker testing, including the Cancer Patient Equity Act of 2021(H.R.5377) - Diagnostic regulatory reforms, including the Verifying Accurate Leading-edge IVCT Development Act of 2023 (H.R.2369) and the pilot program for Oncology Drug Products Used with Certain In Vitro Diagnostic Tests - Cancer Moonshot
MMM - Medicare/Medicaid HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 2 - HOUSE OF REPRESENTATIVES 139 - Natl Institutes of Health (NIH) 1 - SENATE 12 - White House Office
FOUNDATION MEDICINE, INC.
150 Second Street, Cambridge, MA, 02141, US
JENNIFER ROMANS JENNIFER ROMANS